EFFICACY OF THE CLM-022, AN INHIBITOR OF THE NLRP3 INFLAMMASOME, IN IN VIVO AND IN VITRO PATHOGEN-ASSOCIATED MOLECULAR PATTERNS (PAMPS)-INDUCED DISEASE MODELS

CLM-022 - Genfit

https://journals.lww.com/hep/fulltext/2025/10001/the_liver_meeting__2025_abstracts.1.aspx

Guillaume Vidal1; Alexandra Caron1; Hana El Khatib1; Maryse Malysiak1; Valérie Daix1; Simon Debaecker1; Manon Clarisse1; Dean Hum2; Bart Staels3; Sakina Sayah Jeanne1

Oct 8, 2025